Cancer Straight Talk Podcast

For nearly half of all breast cancer patients – those with low levels of the HER2 protein – targeted treatment options have always been limited. Palliative chemo has been the standard of care in stage 4 metastatic patients – until now.

You’ve received a cancer diagnosis. Now what? For George Kolasa, it was obvious: use his glioblastoma diagnosis for good. “I’ve been chosen."

A recent clinical trial for rectal cancer headed up by Memorial Sloan Kettering has grabbed the attention of medical oncologists and cancer scientists around the world. Like a miracle, in a subset of patients with the right genetic makeup, an IV infusion of an immunotherapy caused a complete remission. The doctors were shocked. The cancer disappeared in every single patient enrolled on trial. The results are so impressive they were published in The New England Journal of Medicine and featured at the nation’s largest gathering of clinical oncologists in June 2022.

One of the most universal and devastating side effects of cancer is financial toxicity. Learn tips for choosing the right insurance plan, oral versus IV treatments, planning ahead and resources for aid.

What makes a good pain remedy– chemically, mentally, legally? Is it better as an edible, oil or vapor? How does one even begin to figure out dosing?

Andrew and his wife, Kelly, talk about their struggle to save not just Andrew’s life but also their marriage and personal identities.

Learn about the impacts of cancer and its treatment on men’s sexual health, and get advice for regaining sexual function.

Every year, tens of thousands of people across the country hop on stationary bikes to raise money for rare cancer research. How did this phenomenon start? And who is that money helping?

How does one find gratitude while living with cancer? Can gratitude and grief exist at the same time? Hear past guests of the podcast share what they're grateful for, and learn some tools for managing your grief.

In this episode, Dr. Diane Reidy-Lagunes talks with Dr. Sawyers about what’s next in the field of cancer pharmaceuticals. Is another silver bullet on the horizon?